Latest filing published 07 Jan 2026 for ZEVRA THERAPEUTICS, INC., €370k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 40 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +89.5%Entry US$6.37 · Close at T+365 US$12.07
- +38.9%Entry US$5.27 · Close at T+365 US$7.32
- -13.1%Entry US$5.40 · Close at T+365 US$4.69
- +31.1%Entry US$4.79 · Close at T+365 US$6.28
- -2.2%Entry US$5.95 · Close at T+365 US$5.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
R. LaDuane Clifton: trading record in brief
R. LaDuane Clifton has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Zevra Therapeutics, Inc. and LGL Group Inc. We count 48 filings; the first trade dates from 7 April 2010 and the latest from 31 December 2025.
In open-market terms, that means 40 purchases worth €97k on one side and 1 sale worth €83k on the other. On balance, insiders were net buyers of €14k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 5 share grants and 2 option exercises.
In size, the median ticket on the buying side is €1,753. Of 37 purchases, 26 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. Looking at 40 purchases old enough to measure, the stock rose over the following 90 days in 30% of cases; the median change was -10.1%. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 7 January 2026 with a share grant (€370k) in Zevra Therapeutics, Inc. The clock since the last published purchase (17 July 2024) now reads 845 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to R. LaDuane Clifton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 48,513 shares@ US$8.9667.4% of flowCommon StockSEC:0001488774-26-000002:1
- 140,667 shares0Common StockSEC:0001488774-26-000002:0
- 11,000 shares@ US$7.86177.6% of flowCommon StockSEC:0001437749-25-004068:0
- 43,333 sharesCommon StockSEC:0001437749-25-002625:0
- 2,000 shares@ US$6.7711.5% of flowCommon StockSEC:0001437749-24-022939:0Canonical exit: 15 Oct 2024 (T+90)
- 1,000 shares@ US$4.95914.3% of flowCommon StockSEC:0001437749-23-025317:0Canonical exit: 5 Dec 2023 (T+90)
- 2,000 shares@ US$4.951.7% of flowCommon StockSEC:0001437749-23-015140:1Canonical exit: 16 Aug 2023 (T+90)
- 689 shares@ US$4.950.6% of flowCommon StockSEC:0001437749-23-015140:2Canonical exit: 16 Aug 2023 (T+90)
- 51 shares@ US$4.940.2% of flowCommon StockSEC:0001437749-23-015140:0Canonical exit: 16 Aug 2023 (T+90)
- 1,725 shares@ US$4.156.3% of flowCommon StockSEC:0001437749-23-006277:0Canonical exit: 8 Jun 2023 (T+90)
- 25 shares@ US$5.590.0% of flowCommon StockSEC:0001437749-23-001060:1Canonical exit: 13 Apr 2023 (T+90)
- 610 shares@ US$5.8211.3% of flowCommon StockSEC:0001437749-23-001060:0Canonical exit: 13 Apr 2023 (T+90)
- 400 shares@ US$5.980.4% of flowCommon StockSEC:0001437749-22-023512:1Canonical exit: 29 Dec 2022 (T+90)
- 600 shares@ US$5.9812.7% of flowCommon StockSEC:0001437749-22-023512:0Canonical exit: 29 Dec 2022 (T+90)
- 1,200 shares@ US$4.999219.9% of flowCommon StockSEC:0001437749-22-012932:0Canonical exit: 16 Aug 2022 (T+90)
- 510 shares@ US$8.2913.0% of flowCommon StockSEC:0001437749-21-027098:0Canonical exit: 16 Feb 2022 (T+90)
- 215 shares@ US$9.386.0% of flowCommon StockSEC:0001437749-21-022841:0Canonical exit: 28 Dec 2021 (T+90)
- 935 shares@ US$8.586523.7% of flowCommon StockSEC:0001437749-21-022431:0Canonical exit: 19 Dec 2021 (T+90)
- 230 shares@ US$9.1056.1% of flowCommon StockSEC:0001437749-21-021308:0Canonical exit: 30 Nov 2021 (T+90)
- 75 shares@ US$14.113.1% of flowCommon StockSEC:0001437749-21-015562:0Canonical exit: 21 Sept 2021 (T+90)
- 150 shares@ US$9.854.2% of flowCommon StockSEC:0001437749-21-013577:0Canonical exit: 25 Aug 2021 (T+90)
- 1,000 shares@ US$0.8390.5% of flowCommon StockSEC:0001437749-20-018766:0Canonical exit: 24 Nov 2020 (T+90)
- 2,000 shares@ US$0.6950.8% of flowCommon StockSEC:0001437749-20-018274:0Canonical exit: 16 Nov 2020 (T+90)
- 1,500 shares@ US$0.19230.2% of flowCommon StockSEC:0001437749-20-012894:0Canonical exit: 9 Sept 2020 (T+90)
- 11,500 shares@ US$0.1831.3% of flowCommon StockSEC:0001437749-20-011741:0Canonical exit: 24 Aug 2020 (T+90)
25 of 48 declarations
